Director/PDMR Shareholding

Inspiration Healthcare Group PLC

23 July 2024

 

23 July 2024

Inspiration Healthcare Group plc

("Inspiration Healthcare", the "Company" or the "Group")

Director / PDMR Dealing

Inspiration Healthcare Group plc (AIM: IHC), the global medical technology company, announces that Neil Campbell, Non-Executive Director, has gifted a total of 71,428 ordinary shares of 10 pence each in the capital of the Company ("Ordinary Shares") to his children, Oliver Campbell and Edward Campbell, for nil consideration.  This is in accordance with Neil Campbell's intention, as stated in the Company's Result of Placing and Subscription announcement on 26 June 2024.

The 71,428 Ordinary Shares are being gifted equally, with 35,714 Ordinary Shares to Oliver Campbell and 35,714 Ordinary Shares to Edward Campbell.  Oliver and Edward Campbell are both PCAs of Neil Campbell.

Following the transfer, Neil Campbell holds 4,416,646 Ordinary Shares representing approximately 4.93% of the Company's issued share capital, Oliver Campbell holds 43,330 Ordinary Shares representing approximately 0.05% of the Company's issued share capital, and Edward Campbell holds 35,714 Ordinary Shares representing approximately 0.04% of the Company's issued share capital.

The information below, set out in accordance with the requirements of the UK Market Abuse Regulation, provides further detail on the shares gifted.

 For further information:

Inspiration Healthcare Group plc                                 Tel: [phone] Roy Davis, Executive Chair and Interim CEO Alan Olby, Chief Financial Officer Liberum (Nominated Adviser & Broker)                                 Tel: [phone] Richard Lindley, Will King, Joshua Borlant Walbrook PR Ltd (Media and Investor Relations)                                 Tel: [phone] or [e-mail] Anna Dunphy, Stephanie Cuthbert, Louis Ashe-Jepson

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Neil Campbell
2	Reason for the notification
a)	Position/status	PDMR - Non-Executive Director
b)	Initial notification /Amendment	Initial
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Inspiration Healthcare Group plc
b)	LEI	213800GKFT3ENAPMDL15
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary Shares of 10p each in the capital of the Company ISIN: GB00BXDZL105
b)	Nature of the transaction	Gift of shares to his children
c)	Price(s) and volume(s)	Price(s) Volume(s) Nil 71,428
d)	Aggregated information - Aggregated volume - Price	N/A - single transaction
e)	Date of the transaction	23 July 2024
f)	Place of the transaction	Outside of a trading venue

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Oliver Campbell
2	Reason for the notification
a)	Position/status	PCA of Neil Campbell, Non-Executive Director
b)	Initial notification /Amendment	Initial
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Inspiration Healthcare Group plc
b)	LEI	213800GKFT3ENAPMDL15
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary Shares of 10p each in the capital of the Company ISIN: GB00BXDZL105
b)	Nature of the transaction	Receipt of shares from Neil Campbell
c)	Price(s) and volume(s)	Price(s) Volume(s) Nil 35,714
d)	Aggregated information - Aggregated volume - Price	N/A - single transaction
e)	Date of the transaction	23 July 2024
f)	Place of the transaction	Outside of a trading venue

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Edward Campbell
2	Reason for the notification
a)	Position/status	PCA of Neil Campbell, Non-Executive Director
b)	Initial notification /Amendment	Initial
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Inspiration Healthcare Group plc
b)	LEI	213800GKFT3ENAPMDL15
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary Shares of 10p each in the capital of the Company ISIN: GB00BXDZL105
b)	Nature of the transaction	Receipt of shares from Neil Campbell
c)	Price(s) and volume(s)	Price(s) Volume(s) Nil 35,714
d)	Aggregated information - Aggregated volume - Price	N/A - single transaction
e)	Date of the transaction	23 July 2024
f)	Place of the transaction	Outside of a trading venue

About Inspiration Healthcare Group plc 

Inspiration Healthcare (AIM: IHC) designs, manufactures and markets pioneering medical technology. Based in the UK, the Company specialises in neonatal intensive care medical devices, which are addressing a critical need to help to save the lives and improve the outcomes of patients, starting with the very first breaths of life.

The Company has a broad portfolio of its own products and complementary distributed products, for use in neonatal intensive care designed to support even the most premature babies throughout their hospital stay. Its own branded products range from highly sophisticated capital equipment such as ventilators for life support through to single-use disposables.

The Company sells its products directly to hospitals and healthcare providers in the UK and Ireland, where it also distributes a range of advanced medical technologies for infusion therapy.  In the rest of the world the Company has an established network of distribution partners around the world giving access to more than 75 countries.

The Company operates in the UK from its world-class Manufacturing and Technology Centre in Croydon, South London and in the USA from its facility in Melbourne, Florida.

Further information on Inspiration Healthcare can be found at www.inspirationhealthcaregroup.com.

 

END